Auto-populated list of related Clinical Trials
(Breast, Cleft Lip and Palate, Hand, Lymphedema, Oral, Skin, Trauma)
No trials match your search ""
-
Magnetic Resonance Imaging of Breast Cancer
Stanford is currently accepting patients for this trial. -
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
Stanford is currently accepting patients for this trial. -
Phase II Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
Stanford is currently accepting patients for this trial. -
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
Stanford is currently accepting patients for this trial. -
A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers
Stanford is currently accepting patients for this trial. -
An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic
Stanford is currently accepting patients for this trial. -
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
Stanford is currently accepting patients for this trial. -
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
Stanford is currently accepting patients for this trial. -
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
Stanford is currently accepting patients for this trial. -
Study of Infigratinib in Combination With Tamoxifen or With Fulvestrant and Palbociclib in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
Stanford is currently accepting patients for this trial. -
Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT
Stanford is currently accepting patients for this trial. -
68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer
Stanford is currently accepting patients for this trial. -
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
Stanford is currently accepting patients for this trial. -
Pivotal Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients
Stanford is currently accepting patients for this trial. -
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
Stanford is currently accepting patients for this trial. -
Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer
Stanford is currently accepting patients for this trial. -
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Stanford is currently accepting patients for this trial. -
Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA
Stanford is currently accepting patients for this trial. -
Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy
Stanford is currently accepting patients for this trial. -
Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer
Stanford is currently accepting patients for this trial.
No trials match your search ""
No trials match your search ""
No trials match your search ""
No trials match your search ""
No trials match your search ""
-
Lymphedema Study for Arm or Leg Lymphedema
Stanford is currently accepting patients for this trial. -
International Lymphatic Disease and Lymphedema Registry
Stanford is currently accepting patients for this trial.
-
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
Stanford is currently accepting patients for this trial.
-
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma
Stanford is currently accepting patients for this trial. -
Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma
Stanford is currently accepting patients for this trial. -
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
Stanford is currently accepting patients for this trial. -
Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer, STAMP Study
Stanford is currently accepting patients for this trial. -
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
Stanford is currently accepting patients for this trial. -
Assessment of Patient Experience During Treatment for Cancer
Stanford is currently accepting patients for this trial. -
Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms
Stanford is currently accepting patients for this trial. -
A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)
Stanford is currently accepting patients for this trial.
-
Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds
Stanford is currently accepting patients for this trial. -
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Stanford is currently accepting patients for this trial. -
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Stanford is currently accepting patients for this trial. -
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer
Stanford is currently accepting patients for this trial. -
Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway Activation
Stanford is currently accepting patients for this trial. -
Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
Stanford is currently accepting patients for this trial. -
Ipilimumab +Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma
Stanford is currently accepting patients for this trial. -
Phase 1 Study of SQ3370 in Patients With Advanced Solid Tumors
Stanford is currently accepting patients for this trial. -
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Stanford is currently accepting patients for this trial. -
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
Stanford is currently accepting patients for this trial. -
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors
Stanford is currently accepting patients for this trial.
-
Detection of Immune Changes as a Result of Surgical Trauma in Human Subject
Stanford is currently accepting patients for this trial.